Endoscopic resection of bladder cancer in patients receiving double platelet antiaggregant therapy

Surgical Endoscopy

Volumn 25, Issue 7, 2011, Pages 2281-2287

  Carmignani, Luca ^a   Picozzi, Stefano ^a   Stubinski, Robert ^a   Casellato, Stefano ^a   Bozzini, Giorgio ^a   Lunelli, Luca ^a   Arena, Domenico ^a  

^a IRCCS POLICLINICO SAN DONATO   (Italy)

Author keywords

Bladder; Cancer; Coronary artery stenting; Double platelet antiaggregant therapy; Transurethral resection of bladder cancer

Indexed keywords

ACETYLSALICYLIC ACID PLUS CLOPIDOGREL; HEMOGLOBIN;

ADULT; AGED; ARTICLE; BLADDER CANCER; BLOOD CLOT; CANCER SURGERY; CATHETER REMOVAL; CATHETERIZATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SAFETY; ENDOSCOPIC SURGERY; FEMALE; HEART DISEASE; HEMATURIA; HEMOGLOBIN BLOOD LEVEL; HUMAN; MALE; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; TRANSURETHRAL RESECTION; TREATMENT DURATION; TREATMENT RESPONSE; URINE RETENTION;

EID: 79960429086     PISSN: 09302794     EISSN: 14322218     Source Type: Journal    
DOI: 10.1007/s00464-010-1549-1     Document Type: Article

References (25)

1. Steinhubl SR, Berger PB, Mann JT III, Fry ET, DeLago A, Wilmer C, Topol EJ, CREDO Investigators, Clopidogrel for the Reduction of Events During Observation (2002) Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 288:2411-2420
2. L Gregorini J Marco J Fajadet M Bernies B Cassagneau P Brunel IM Bossi PM Mannucci 1997 Ticlopidine and aspirin pretreatment reduces coagulation and platelet activation during coronary dilation procedures J Am Coll Cardiol 29 13 20 8996289 10.1016/S0735-1097(96)00428-7 1:CAS:528:DyaK2sXntVKmsw%3D%3D (Pubitemid 27028714)
3. T Chechi S Vecchio G Vittori G Giuliani A Lilli G Spaziani L Consoli G Baldereschi GG Biondi-Zoccai I Sheiban M Margheri 2008 ST-segment elevation myocardial infarction due to early and late stent thrombosis a new group of high-risk patients J Am Coll Cardiol 51 2396 2402 18565395 10.1016/j.jacc.2008. 01.070 (Pubitemid 351833104)
4. S Mayor 2006 Drug eluting stents are safe for licensed indications, FDA panel says BMJ 333 1235 17170397 10.1136/bmj.39063.481285.DB
5. S Silber P Albertsson FF Avilés PG Camici A Colombo C Hamm E Jørgensen J Marco JE Nordrehaug W Ruzyllo P Urban GW Stone W Wijns 2005 Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology Eur Heart J 26 804 847 15769784 10.1093/eurheartj/ehi564
6. MN Vicenzi T Meislitzer B Heitzinger M Halaj LA Fleisher H Metzler 2006 Coronary artery stenting and non-cardiac surgery-a prospective outcome study Br J Anaesth 96 686 693 16670113 10.1093/bja/ael083 1:STN:280: DC%2BD283mslKktw%3D%3D (Pubitemid 43786682)
7. JM O'Riordan RJ Margey G Blake PR O'Connell 2009 Antiplatelet agents in the perioperative period Arch Surg 144 69 76 19153328 10.1001/archsurg.144.1.69
8. MJ Luckie RS Khattar DG Fraser 2009 Noncardiac surgery and antiplatelet therapy following coronary artery stenting Heart 95 1303 1308 19218260 10.1136/hrt.2008.161273 1:CAS:528:DC%2BD1MXht1WnsLjL
9. Grines CL, Bonow RO, Casey DE Jr, Gardner TJ, Lockhart PB, Moliterno DJ, O'Gara P, Whitlow P (2007) Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation 115:813-818 (Pubitemid 46294748)
10. EP McFadden E Stabile E Regar E Cheneau AT Ong T Kinnaird WO Suddath NJ Weissman R Torguson KM Kent AD Pichard LF Satler R Waksman PW Serruys 2004 Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy Lancet 364 1519 1521 15500897 10.1016/S0140-6736(04)17275-9 1:CAS:528:DC%2BD2cXovVKrtrs%3D (Pubitemid 39410418)
11. A Jeremias B Sylvia J Bridges AJ Kirtane B Bigelow DS Pinto KK Ho DJ Cohen LA Garcia DE Cutlip JP Carrozza Jr 2004 Stent thrombosis after successful sirolimus-eluting stent implantation Circulation 109 1930 1932 15078797 10.1161/01.CIR.0000127105.99982.21 (Pubitemid 38544480)
12. I Iakovou T Schmidt E Bonizzoni L Ge GM Sangiorgi G Stankovic F Airoldi A Chieffo M Montorfano M Carlino I Michev N Corvaja C Briguori U Gerckens E Grube A Colombo 2005 Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents JAMA 293 2126 2130 15870416 10.1001/jama.293.17.2126 1:CAS:528:DC%2BD2MXjvFKiu7w%3D (Pubitemid 40617065)
13. E Ferrari M Benhamou P Cerboni B Marcel 2005 Coronary syndromes following aspirin withdrawal: a special risk for late stent thrombosis J Am Coll Cardiol 45 456 459 15680728 10.1016/j.jacc.2004.11.041 1:CAS:528:DC%2BD2MXoslChug%3D%3D (Pubitemid 40186800)
14. AT Ong A Hoye J Aoki CA van Mieghem GA Rodriguez Granillo K Sonnenschein E Regar EP McFadden G Sianos WJ van der Giessen PP de Jaegere P de Feyter RT van Domburg PW Serruys 2005 Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation J Am Coll Cardiol 45 947 953 15766834 10.1016/j.jacc.2004.09.079 1:CAS:528:DC%2BD2MXit1Cju78%3D (Pubitemid 40342824)
15. P Urban AH Gershlick G Guagliumi P Guyon C Lotan J Schofer A Seth JE Sousa W Wijns C Berge M Deme HP Stoll 2006 Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry Circulation 113 1434 1441 16534015 10.1161/CIRCULATIONAHA.104.532242 1:CAS:528:DC%2BD28Xitlegtbk%3D (Pubitemid 43739440)
16. S Tsimikas 2006 Drug-eluting stents and late adverse clinical outcomes J Am Coll Cardiol 47 2112 2115 16697332 10.1016/j.jacc.2006.03.019 1:CAS:528:DC%2BD28XksFalsbY%3D
17. R Virmani A Farb G Guagliumi FD Kolodgie 2004 Drug-eluting stents: caution and concerns for long-term outcome Coron Artery Dis 15 313 318 15346088 10.1097/00019501-200409000-00003 (Pubitemid 39299245)
18. EL Eisenstein KJ Anstrom DF Kong LK Shaw RH Tuttle DB Mark JM Kramer RA Harrington DB Matchar DE Kandzari ED Peterson KA Schulman RM Califf 2007 Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation JAMA 297 159 168 17148711 10.1001/jama.297.2.joc60179 1:CAS:528:DC%2BD2sXksVKrtw%3D%3D (Pubitemid 46089732)
19. G Tanzilli C Greco F Pelliccia V Pasceri F Barillà V Paravati G Pannitteri C Gaudio E Mangieri 2009 Effectiveness of two-year clopidogrel + aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [Two-Year ClOpidOgrel Need] study) Am J Cardiol 104 1357 1361 19892050 10.1016/j.amjcard.2009.07.002 1:CAS:528: DC%2BD1MXhtlyjt77P
20. AM Galløe L Thuesen H Kelbaek P Thayssen K Rasmussen PR Hansen N Bligaard K Saunamäki A Junker J Aarøe U Abildgaard J Ravkilde T Engstrøm JS Jensen HR Andersen HE Bøtker S Galatius SD Kristensen JK Madsen LR Krusell SZ Abildstrøm GB Stephansen JF Lassen 2008 Comparison of paclitaxel- and sirolimus-eluting stents in everyday clinical practice JAMA 299 409 416 18230778 10.1001/jama.299.4.409 (Pubitemid 351185949)
21. SR Mehta S Yusuf RJ Peters ME Bertrand BS Lewis MK Natarajan K Malmberg H Rupprecht F Zhao S Chrolavicius I Copland KA Fox 2001 Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study Lancet 358 527 533 11520521 10.1016/S0140-6736(01)05701-4 1:CAS:528:DC%2BD3MXmtV2ht7g%3D (Pubitemid 32772726)
22. FI de Korte JW van Werkum PL Vijverberg JM Ten Berg 2008 Late coronary stent thrombosis complicating urologic surgery Eur Urol 54 221 225 17964710 10.1016/j.eururo.2007.10.005 (Pubitemid 351713671)
23. L Carmignani S Picozzi 2009 Re: non-cardiac surgery and antiplatelet therapy following coronary artery stenting Heart 95 1537 19717703 10.1136/hrt.2009.174474 1:STN:280:DC%2BD1MrptVSlsQ%3D%3D
24. R Sylvester W Oosterlinck A van der Meijden 2004 A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials J Urol 71 2186 2190 10.1097/01.ju.0000125486. 92260.b2 (Pubitemid 38625431)
25. RJ Sylvester AP van der Meijden W Oosterlinck A Witjes C Bouffioux L Denis D Newling K Kurth 2006 Predicting recurrence and progression in individual patients with stage TaT1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials Eur Urol 49 466 477 16442208 10.1016/j.eururo.2005.12.031 (Pubitemid 43259554)